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Abstract
Background Acute non-variceal upper gastrointestinal
bleeding (ANVB) or hemorrhage (used interchangeably) is
an emergency. Endoscopically applied hydrogen peroxide
(H2O2) has been shown to improve visualization of the
ulcer base.
Aims To test the hypothesis that ulcer base clot clearance
with 3% H2O2 improves the visualization of ANVB lesions
compared to water alone.
Methods In this single-center prospective study, 320
patients with ANVB were examined, of which 81 met the
entry criteria for evaluation. All patients with ANVB
underwent urgent endoscopy. Those with adherent clots on
the ulcer base were sprayed with 250 ml of water, followed
by up to 100 ml of 3% H2O2. The main outcome mea-
surement was Kalloo’s Visual Scores of the ulcer base
before and after water and H2O2.
Results Eighty-one patients with gastric ulcers (GU; 34)
and duodenal ulcers (DU; 47) met the entry criteria. The
mean improvement in grade from water to H2O2 was 2.04
(95% conﬁdence interval [CI] (1.86, 2.23)). The mean
volume of H2O2 used to clear clots was higher (70 ml) in
patients who were negative for both Helicobacter pylori
and non-steroidal anti-inﬂammatory drug (NSAID) use
than in those who were positive for both (31 ml)
(P = 0.00). More DU patients (72%) had visible vessels
than GU patients (44%) (P = 0.01).
Conclusions H2O2 improved the visualization of ulcer
bases in ANVB. A smaller volume of H2O2 was required to
clear clots in patients who used NSAIDs and had H. pylori
infection. H2O2 identiﬁed more DU vessels. The use of
H2O2 should be considered as a standard therapy in the
management of clots in ANVB.
Keywords Non-variceal bleeding  Endoscopy 
Ulcer clot  Hydrogen peroxide
Introduction
Upper gastrointestinal bleeding, a potentially lethal medi-
cal emergency, is a common cause for intensive care unit
(ICU) admission. Bleeding is the most frequent compli-
cation of peptic ulcer disease, comprising 30–50% of all
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DOI 10.1007/s10620-009-0948-4complications [1, 2]. Peptic ulcer bleeding incidences in
published studies vary from 6 to 78%, depending on the
geographic location of the study center [3].
During the past ten years, early endoscopy has been
shown to signiﬁcantly decrease the hospitalization days for
patients with complicated peptic ulcer disease, especially
for those with acute non-variceal bleeding (ANVB) [4].
Another advantage in performing early endoscopy on such
patients is that it allows the endoscopist to assess the
bleeding site by visualizing the base of the culprit lesion.
This, in turn, facilitates more timely diagnosis, accurate
assessment of the bleeding lesion, and endoscopic therapy
(if needed), all of which ultimately reduce the likelihood of
rebleeding [5, 6]. These facts point to the importance of
early endoscopy in the management of patients with ANVB.
It has been previously shown that early endoscopic
therapy in ANVB is necessary for ulcers that have high-risk
stigmata of rebleeding, such as actively spurting vessel,
non-bleeding vessel, or ulcers with adherent clot, because
each of them carries a rebleeding risk of 90%, 50%, and
30%, respectively, if endoscopic therapy is not offered. A
lower risk of rebleeding is seen in patients having ulcers
with pigmented spots (10%) or clean base (5%) [7–9]. But,
early endoscopy in ANVB can be challenging, especially
whenbloodandclotsarepresent,obscuringthevisualization
of bleeding lesions that may prevent appropriate stratiﬁca-
tion of the risk of rebleeding. An adherent clot may simply
coverapigmentedspotoracleanbasewhichcarryalowrisk
of rebleeding (10% and 5%, respectively) and are generally
shown to not require endoscopic therapy [10–13]; an
adherent clotmaymaskanunderlyingvesselwhich carries a
high risk of rebleeding (50%) and is therefore shown to
require endoscopic therapy [5, 6]. Hence, it is extremely
important to clear the adherent clot from the ulcer base and
to visualize it in order to accurately assess the prognosis and
to direct speciﬁc endoscopic treatment if indicated. This, in
turn, results in improved outcomes for patients, i.e., lesser
chance of rebleeding and its associated complications.
Several methods have been used to remove adherent clots,
such as vigorous washing with water and endoscopic
removalbyusingasnare.Recentstudieshaveshownthatthe
removal of adherent clots by mechanical methods (shaving
or trimming) without disturbing the pedicle may facilitate
endoscopic therapy [14]. More recently, 3% hydrogen per-
oxide (H2O2) solution has been used in a few animal and
small-samplehumanstudiestocleartheadherentbloodclots
to gain better visibility of the ulcer bases [15–17]. The
rationale for using H2O2 is that it oxidizes the hemoglobin
thus rendering the pigmented blood clot translucent and
helping in its dissolution [18–20]. Additionally, its potential
hemostatic effect may add to the list of adjunct therapies
in the endoscopic management [21–23]. This is the ﬁrst
large-sample human study conducted so far to evaluate
the efﬁcacy of H2O2 in the visualization of ulcer bases. We
tested the hypothesis that cleaning the ulcer base with 3%
H2O2 solution improves the endoscopic visualization of
ANVB lesions compared to cleaning with water alone.
Patients and Methods
All patients aged 18 years or older who presented to a single
tertiary care center between March 2003 and December
2008 with acute upper gastrointestinal bleeding (melena or
fresh blood per rectum or vomiting of fresh blood) were
considered for the study. A total of 320 patients were
evaluated for the study protocol (130 female and 190 male).
An informed written consent was obtained from each of
those patients. Only patients with adherent clots on the ulcer
base were included in the study. The following patients
were excluded from the study: those who were unable to
give consent, those with comorbidities such as severe car-
diac failure, obstructive pulmonary disease, coagulation
disorder, and neurological conditions, those who had a
known allergy or sensitivity to hydrogen peroxide, and
those who had adherent clots larger than 2 cm on an ulcer
base. Therefore, only 81 of the 320 subjects met the
inclusion criterion. The study was approved by the Insti-
tutional Review Board of the medical center.
Emergency upper gastrointestinal endoscopy was per-
formed (Olympus double-channel therapeutic endoscope)
on all patients within 6 h of presentation to the hospital by a
single experienced endoscopist (SS). Upon admission to the
hospital, all patients were administered IV proton pump
inhibitor (PPI) bolus followed by continuous infusion.
Gastric lavage with 500 ml of water was performed on all
patients using a 34Fr, 36’’ Argyle-Edlich Gastric Lavage
Kit
TM before endoscopy. All patients received a combina-
tion of fentanyl and midazolam for sedation prior to the
procedure. Kalloo’s Visual Clearance Scoring System
(Kalloo Scoring) was used to assess the improvement in
visual clearance of the clot from the ulcer bases. The grades
according to this system were: grade ‘‘0’’ for no change,
grade ‘‘1’’ for minimal clearance, grade ‘‘2’’ for good
clearance, and grade ‘‘3’’ for excellent clearance [16].
During endoscopy, a visible vessel was deﬁned as an ele-
vated red, bluish, or pulsatile spot on the ulcer [17]. If clots
were seen, the ulcer base was vigorously sprayed with 5-ml
aliquots of 250 ml sterile water at room temperature mixed
with 5 ml of simethicone using a 5Fr spray tip catheter
attached to a 30-ml syringe and applying a constant pres-
sure. Adherent clots were deﬁned as those resistant to target
water spray [16]. If water spray did not achieve at least a
grade 2 clearance, then 5-ml aliquots of 3% solution of
H2O2 (USP, Cumberland Swan, Smyrna, TN) at room
temperature was sprayed onto the ulcer base using a 5Fr
2428 Dig Dis Sci (2009) 54:2427–2433
123spray tip catheter attached to a 30-ml syringe for up to
100 ml or until achieving a grade 3 clearance. A fresh bottle
of H2O2 was used for each patient. The ulcer bases were
sequentially visually scored before and after water and,
ﬁnally, after hydrogen peroxide spray using Kalloo’s Visual
Clearance Scoring System as mentioned above. Multiple
photographs were obtained at each stage of management for
subsequent evaluation of the grades of visibility of the ulcer
bases by two independent observers. The patient’s stomach
was aspirated repeatedly and completely after each aliquot
of H2O2. The bubbles and effervescence created by H2O2
were thoroughly washed off with approximately 30 ml of
sterile water mixed with simethicone, as described earlier.
The endoscopist proceeded with the standard therapeutic
procedure as deemed appropriate for each patient. Initial
hemostasis was deﬁned as cessation of bleeding for 5 min
after endoscopic therapy. Helicobacter pylori status was
assessed on gastric mucosal biopsies (obtained from the
antrum and the body) by rapid urease test in all patients and
non-steroidal anti-inﬂammatory drug (NSAID) use history
was recorded. All of the study subjects were followed for
48 h in the hospital and subsequently for 30 days after the
index endoscopy for recurrence of bleeding, need for blood
transfusion or surgery, and adverse reaction to H2O2.
The primary end points of the study were Kalloo’s Visual
Clearance Scores before and after water spray and, ﬁnally,
after H2O2. The secondary end point was the volume of
H2O2 used to clear ulcer clots. All statistical analyses were
performed using the software package SPSS 11.5. A uni-
variate repeated measures analysis of variance (ANOVA)
procedure was conducted to study the effect of cleaning the
ulcer base with water and H2O2 on the grades of visibility.
Another univariate ANOVA procedure was conducted to
study the volume of H2O2 required to clean the ulcer base
with factors impacting it, such as age, use of tobacco,
alcohol, PPI and NSAID use, H. Pylori status, and the ulcer
site (duodenal ulcers [DU] or gastric ulcers [GU]). Allof the
photographs were graded independently by two endosco-
pists (SS and RRS) for intra- and inter-observer agreement.
The second endoscopist (RRS) was blinded to the study
results and also to the photographs. Post-hoc analysis was
performed utilizing Tukey’s honestly signiﬁcant differences
(HSD) and Bonferroni’s multiple comparison procedures.
Results
Of the 320 eligible subjects, 81 patients (33 females and 48
males) 22–88 years of age fulﬁlled the entry criteria of the
study (adherentclots on ulcer base). A total of34 GU and 47
DU were noted (Table 1). A total of 40 patients reported a
recent history of NSAID use (for more than 1 month) and
58 patients tested positive for H. pylori on gastric biopsies.
All patients completed the study successfully and none of
them developed adverse effects of H2O2 for up to 48 h after
the procedure (nausea, vomiting, or abdominal pain).
The mean grades of visualization of the ulcer beds prior
to and immediately after water and then after hydrogen
peroxide spraying were obtained. The mean grades were
0.06 before water, 0.78 after water, and 2.83 after H2O2
(Table 2). The mean difference in grade improvements
between water and hydrogen peroxide spray was 2.04 (95%
conﬁdence interval [CI] (1.86, 2.23)). This difference was
found to be statistically signiﬁcant (P = 0.00) (Figs. 1 and
2). H2O2 improved the visibility of both types of peptic
ulcers, but more so in DU than in GU (Fig. 3). The dif-
ference in the improvement in grades from water to H2O2
between DU and GU showed a mean of 0.43 (95% CI 0.03,
0.84) (P = 0.035). In no patient did water spray alone clear
the adherent ulcer base clots (Table 2).
Following clot clearance using H2O2 in the 81 subjects,
49 (60.5%) demonstrated visible vessels and 32 (39.5%)
demonstrated pigmented spots. Further analysis of visible
vessel count using the Chi-square test showed that the
proportion of visible vessels in DU patients (34 of 47
[72%]) was signiﬁcantly higher (P = 0.01) than in GU
patients (15 of 34 [44%]).
The univariate ANOVA procedure conducted to study
the volume of H2O2 required to clean the ulcer base
revealed that NSAID use, H. pylori status, and the ulcer site
were the only signiﬁcant factors impacting the volume
required. Post-hoc analysis of volume such as Tukey’s
HSD and Bonferroni’s multiple comparison procedures
revealed that the mean volume (31 ml) of H2O2 used in
patients who tested positive for H. pylori and also took
NSAIDs was signiﬁcantly lower than the mean volume
(70 ml) used in patients who were negative for both
(P value 0.00). The mean volumes (35 and 33 ml) of
hydrogen peroxide used in patients with DU or GU who
took NSAIDs were signiﬁcantly lower than those of (45
Table 1 Patient demographics
Demographics
Mean age (range 22–88 years) 59 (SD 17.67)
No (%)
Male 48 (59)
Female 33 (41)
H. pylori positive 58 (72)
NSAID use 40 (49)
PPI use 13 (16)
Smoking 22 (27)
Alcohol use 30 (37)
Duodenal ulcers 47 (58)
Gastric ulcers 34 (42)
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123and 56 ml) patients with DU or GU who did not take
NSAIDs (P\0.05, Tamhane and Dunnett T3 multiple
comparison tests) (Table 3, Fig. 4).
The Kappa statistic was calculated to measure the intra-
observer agreement (SS) of the grades of visibility of the
ulcer bases assigned by the primary endoscopist before and
after water, and after H2O2. The agreement was found to be
substantial as well as statistically signiﬁcant for each pair of
grades (Kappa 0.64 (95% CI (0.32, 0.97)), 0.82 (95% CI
(0.72,0.93)),and0.74(95%CI(0.55,0.94))andaP-valueof
0.0001 for each pair). The inter-observer agreement of the
grades of visibility before water, after water, and after H2O2
betweenthe two observers were alsofoundto besubstantial,
Fig. 1 a Before water. b After water. c Effervescence during hydrogen peroxide. d After hydrogen peroxide
Fig. 2 Grades achieved with water and H2O2
Fig. 3 Grades of visibility of gastric and duodenal ulcers (GU and
DU)
Table 2 Grades achieved before and after water and after hydrogen
peroxide
Grades achieved Mean grade Std. error 95% CI
Before water 0.06 0.24 0.01, 0.12
After water 0.78 0.76 0.61, 0.95
After hydrogen peroxide 2.83 0.38 2.74, 2.91
2430 Dig Dis Sci (2009) 54:2427–2433
123as well as statistically signiﬁcant (Kappa 0.78 (95% CI
(0.50, 1)), 0.80 (95% CI (0.70, 0.92)), and 0.75 (95% CI
(0.57, 0.94)) and a P-value of 0.0001 for each pair).
No bleeding was induced during the administration of
H2O2. No further intervention was required for the ulcer bed
visualizationinanyofthestudysubjects.Inthe30-dayfollow
up, one DU patient with a vessel had recurrence of bleeding
on day 2 requiring 2 units of packed red-cell transfusion and
surgery, one DU patient with pigment spot on the ulcer base
had recurrence of bleeding on day 23 requiring endoscopic
therapy, one GU patient with pigmented spot died of com-
plicatedmyocardialinfarctiononday14,andonepatientdied
in a motor vehicle accident on day 19.
Discussion
In this large-number single-center prospective study of 81
subjects presenting with ANVB, excellent improvement in
visualization (improvement to grade 3) of ulcer bases was
achieved after cleaning with 3% H2O2 spray. During the
last ten years, early endoscopy and treatment of ANVB
patients within 24 h of admission has proven to be cost-
effective because it reduces the length of hospitalization.
Emergency upper gastrointestinal endoscopy in patients
with acute gastrointestinal bleeding not only facilitates the
diagnosis and therapy, but it also provides extremely
valuable information regarding the risk of rebleeding and
the need for subsequent surgery. Endoscopic therapy is
usually necessary for ulcers with stigmata of high risk of
rebleeding such as actively spurting, non-bleeding vessel,
or ulcers with adherent clot [14, 24]. Endoscopic therapy is
more straightforward for clearly visible peptic ulcers with
actively spurting vessel or non-bleeding visible vessel, but
for the management of ulcers with adherent clot, it has
been controversial. An adherent clot obscures the under-
lying stigmata of the ulcer base which may be a vessel or a
pigmented spot and therefore the risk of subsequent
bleeding in patients with such clots may be misleadingly
high (50%) or low (10%) [7–9]. Recently, several methods
have been used in an attempt to remove adherent clots;
these include vigorous washing with water and endoscopic
removal by using a snare. These endoscopic methods
adequately enable the endoscopist to visualize bleeding
lesions [10–13], but in some patients, these standard
endoscopic methods may not be sufﬁcient to remove clots
from ANVB sources and hence may lead to improper risk
stratiﬁcation and assessment of prognosis. In these situa-
tions, the use of 3% H2O2 is effective in clearing the
adherent blood clots, allowing for better visualization of
ulcer bases when water irrigation alone is not sufﬁcient.
This would facilitate the appropriate endoscopic assess-
ment and appropriate hemostatic therapy for ANVB.
In our study, the mean volume of hydrogen peroxide
required to achieve grade 3 clearance on Kalloo’s score
was signiﬁcantly lower in patients who tested positive for
H. pylori and who also took NSAIDs. The higher preva-
lence of H. pylori observed amongst DU when compared to
GU patients could explain the reduced volume of H2O2
required to clear clots in the DU patients. This is likely due
to the fact that clots in patients who have had prior NSAID
use and H. pylori infection may be less stable due to the
greater platelet dysfunction. However, further studies must
be done to address this ﬁnding, given the potentially poor
sensitivity of the rapid urease test for H. pylori detection in
those with bleeding ulcers. The clinical signiﬁcance of the
Table 3 Impact of H. pylori state and NSAID use on the volume of H2O2 used
CLO ?ve, NSAID ?ve CLO -ve, NSAID ?ve CLO ?ve, NSAID -ve CLO -ve, NSAID -ve
Number of patients 29 11 29 12
Volume of H2O2
Maximum 40 54 55 100
Q3 35 45 40 70
Median 30 40 35 67
Q1 27 35 35 60
Minimum 20 20 27 55
Mean 31.4 (SD 5.96) 40.9 (SD 9.17) 38.8 (SD 8.31) 70 (SD 15.08)
Fig. 4 Impact of H. pylori state and NSAID use on the volume of
H2O2 used
Dig Dis Sci (2009) 54:2427–2433 2431
123differences in H2O2 volumes required to clear clots in the
other groups remains to be determined.
Our study demonstrated 60% visible vessels and 40%
pigmented spots, which is similar to previous studies on
peptic ulcer stigmata after clot removal using mechanical
methods [25, 26]. It is interesting to note that subgroup
analysis on our study subjects demonstrated a signiﬁcantly
higher number of visible vessels in patients with DU than
GU. We hypothesize that this difference is presumably due
to the presence of larger caliber vessels in the DU bases
when compared to GU bases.
We do acknowledge the fact that our study had a few
limitations such as a subjective scoring system (Kalloo),
lack of control subjects, and a possible introduction of
observer bias, as the primary endoscopist was not blinded
to the study. However, we have shown that the intra- and
inter-observer agreement are substantial and statistically
signiﬁcant, through Kappa statistics, and have, thus, dem-
onstrated the consistency in grading by the primary
endoscopist and his similarity in grading with the inde-
pendent observer. Further validation of our study results by
multicenter trials may be needed. A potential limitation of
the use of H2O2 is that it may not be useful in improving
the visibility of ulcer bases with clots larger than 2 cm.
This was the case in a small number (16) of patients from
our unpublished observations.
H2O2 (3%) is known to be relatively non-toxic and,
accordingly, no adverse effects were encountered in this
trial. H2O2 oxides hemoglobin, and facilitates clot disso-
lution and clearance. Additionally, it has a potential he-
mostatic effect, which may add to other adjunctive
therapies in the endoscopic management of ANVB [19–
23]. We conclude that 3% H2O2 has the potential to be safe
and extremely valuable in the improved visualization of
lesions in patients with ANVB. More importantly, H2O2
effectively identiﬁes visible vessels under adherent clots
without the use of mechanical methods, which are known
to induce bleeding and are technically more difﬁcult to
implement. Therefore, H2O2 may prove to be a better
alternative to mechanical methods for clot removal. Hence,
the use of H2O2 should be considered as a standard therapy
to improve the visualization of ulcers with adherent clots in
patients with ANVB.
Conclusion
What Is Already Known on This Topic
– Hydrogen peroxide has been shown to clear peptic
ulcer clots in animal studies and in small-sample
human studies.
What This Study Adds to Our Knowledge
– This is the ﬁrst large-sample human study wherein
hydrogen peroxide is shown to clear ulcer clots in
patients with acute non-variceal upper gastrointestinal
bleeding.
– Patients who take non-steroidal anti-inﬂammatory
drugs (NSAIDs) and have Helicobacter pylori infection
require a smaller volume of hydrogen peroxide to clear
ulcer clots.
– The use of hydrogen peroxide identiﬁed more visible
vessels in patients with duodenal ulcers than in patients
with gastric ulcers.
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